BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

187 related articles for article (PubMed ID: 15727557)

  • 1. Effects of erythropoietin on brain function.
    Jelkmann W
    Curr Pharm Biotechnol; 2005 Feb; 6(1):65-79. PubMed ID: 15727557
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Recovery of motor spontaneous activity after intranasal delivery of human recombinant erythropoietin in a focal brain hypoxia model induced by CoCl2 in rats.
    Merelli A; Caltana L; Girimonti P; Ramos AJ; Lazarowski A; Brusco A
    Neurotox Res; 2011 Aug; 20(2):182-92. PubMed ID: 21116766
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Experimental evidence of the potential use of erythropoietin by intranasal administration as a neuroprotective agent in cerebral hypoxia.
    Merelli A; Caltana L; Lazarowski A; Brusco A
    Drug Metabol Drug Interact; 2011; 26(2):65-9. PubMed ID: 21756166
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The brain erythropoietin system and its potential for therapeutic exploitation in brain disease.
    Hasselblatt M; Ehrenreich H; Sirén AL
    J Neurosurg Anesthesiol; 2006 Apr; 18(2):132-8. PubMed ID: 16628067
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Erythropoietin and the hypoxic brain.
    Marti HH
    J Exp Biol; 2004 Aug; 207(Pt 18):3233-42. PubMed ID: 15299044
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Biology of erythropoietin.
    Jelkmann W; Hellwig-Bürgel T
    Adv Exp Med Biol; 2001; 502():169-87. PubMed ID: 11950137
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Erythropoietin and the brain: from neurodevelopment to neuroprotection.
    Buemi M; Cavallaro E; Floccari F; Sturiale A; Aloisi C; Trimarchi M; Grasso G; Corica F; Frisina N
    Clin Sci (Lond); 2002 Sep; 103(3):275-82. PubMed ID: 12193153
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Use of recombinant human erythropoietin as an antianemic and performance enhancing drug.
    Jelkmann W
    Curr Pharm Biotechnol; 2000 Jul; 1(1):11-31. PubMed ID: 11467358
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Erythropoietin (epoetin) as a protective factor for the brain.
    Malhotra S; Nijhawan S; Rosenbaum DM
    Curr Atheroscler Rep; 2004 Jul; 6(4):301-6. PubMed ID: 15191705
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The biology of erythropoietin in the central nervous system and its neurotrophic and neuroprotective potential.
    Dame C; Juul SE; Christensen RD
    Biol Neonate; 2001; 79(3-4):228-35. PubMed ID: 11275657
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Erythropoietin and the nervous system.
    Genc S; Koroglu TF; Genc K
    Brain Res; 2004 Mar; 1000(1-2):19-31. PubMed ID: 15053948
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Differential neuroprotective properties of endogenous and exogenous erythropoietin in a mouse model of traumatic brain injury.
    Shein NA; Grigoriadis N; Alexandrovich AG; Simeonidou C; Spandou E; Tsenter J; Yatsiv I; Horowitz M; Shohami E
    J Neurotrauma; 2008 Feb; 25(2):112-23. PubMed ID: 18260794
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Erythropoietin prevents motor neuron apoptosis and neurologic disability in experimental spinal cord ischemic injury.
    Celik M; Gökmen N; Erbayraktar S; Akhisaroglu M; Konakc S; Ulukus C; Genc S; Genc K; Sagiroglu E; Cerami A; Brines M
    Proc Natl Acad Sci U S A; 2002 Feb; 99(4):2258-63. PubMed ID: 11854521
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Molecular biology of erythropoietin.
    Jelkmann W
    Intern Med; 2004 Aug; 43(8):649-59. PubMed ID: 15468961
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Hypoxia-induced stroke tolerance in the mouse is mediated by erythropoietin.
    Prass K; Scharff A; Ruscher K; Löwl D; Muselmann C; Victorov I; Kapinya K; Dirnagl U; Meisel A
    Stroke; 2003 Aug; 34(8):1981-6. PubMed ID: 12829864
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Erythropoietin as a novel neuroprotectant.
    Genc S; Koroglu TF; Genc K
    Restor Neurol Neurosci; 2004; 22(2):105-19. PubMed ID: 15272145
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The neuroprotective effect of erythropoietin-transduced human mesenchymal stromal cells in an animal model of ischemic stroke.
    Cho GW; Koh SH; Kim MH; Yoo AR; Noh MY; Oh S; Kim SH
    Brain Res; 2010 Sep; 1353():1-13. PubMed ID: 20547143
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The pleiotropic effects of erythropoietin in the central nervous system.
    Buemi M; Cavallaro E; Floccari F; Sturiale A; Aloisi C; Trimarchi M; Corica F; Frisina N
    J Neuropathol Exp Neurol; 2003 Mar; 62(3):228-36. PubMed ID: 12638727
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Non-erythroid functions of erythropoietin.
    Gassmann M; Heinicke K; Soliz J; Ogunshola OO
    Adv Exp Med Biol; 2003; 543():323-30. PubMed ID: 14713131
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The effects of systemically administered methylprednisolone and recombinant human erythropoietin after acute spinal cord compressive injury in rats.
    Cetin A; Nas K; Büyükbayram H; Ceviz A; Olmez G
    Eur Spine J; 2006 Oct; 15(10):1539-44. PubMed ID: 16547753
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.